Lin‐wen Wu
Impact in
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Bioactive Compounds and Antitumor Agents 1
- Co-authors
- Chong ZhangNengming LinYang-ling LiXiu HuLinghui ZengHuajian ZhuJiankang ZhangRamendra K. Kundu
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Cancer Cell International (2 papers)Cancer Biology and Medicine (1 paper)OncoTargets and Therapy (1 paper)Frontiers in Chemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lin‐wen Wu
18 papers receiving 376 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 82
- Physiology 18
- Hematology 41
- Molecular Biology 225
- Oncology 88
Countries citing papers authored by Lin‐wen Wu
This map shows the geographic impact of Lin‐wen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐wen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐wen Wu more than expected).
Fields of papers citing papers by Lin‐wen Wu
This network shows the impact of papers produced by Lin‐wen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐wen Wu. The network helps show where Lin‐wen Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin‐wen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2022 | 16 | |
| 3 | 2022 | 12 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 21 | |
| 8 | 2020 | 65 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 15 | |
| 11 | 2019 | 19 | |
| 12 | 2019 | 37 | |
| 13 | 2019 | 36 | |
| 14 | 2019 | 5 | |
| 15 | 2018 | 19 | |
| 16 | 2018 | 24 | |
| 17 | 2018 | 10 | |
| 18 | 1998 | 62 |
About Lin‐wen Wu
Lin‐wen Wu is a scholar working on Biological Psychiatry, Toxicology, Physiology, Oncology and Molecular Biology, having authored 18 papers that have together received 381 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Cancer Mechanisms and Therapy (2 papers), Immune Cell Function and Interaction (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer therapeutics and mechanisms (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Cancer Research (82 citations), Physiology (18 citations), Hematology (41 citations), Molecular Biology (225 citations) and Oncology (88 citations). Lin‐wen Wu has collaborated with scholars based in China and United States. Frequent co-authors include Chong Zhang, Nengming Lin, Yang-ling Li, Xiu Hu, Linghui Zeng, Huajian Zhu, Jiankang Zhang, Ramendra K. Kundu, Frank Sangiorgi and Robert E. Maxson. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cancer Cell International, Cancer Biology and Medicine, OncoTargets and Therapy and Frontiers in Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.